Yarrow Bioscience, Inc. SEC filings YARW
Yarrow Bioscience, Inc. has 682 filings in SEC EDGAR's recent list, going back to Jan 7, 2013. Its latest annual report, Form ARS, was filed on Jun 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Nov 12, 2025 | Dec 12, 2025 |
| DEF 14A | Proxy statement | Nov 12, 2024 | Dec 12, 2024 |
| DEF 14A | Proxy statement | Nov 13, 2023 | Dec 13, 2023 |
| DEF 14A | Proxy statement | Nov 25, 2022 | Jan 12, 2023 |
| PRE 14A | Preliminary proxy statement | Nov 14, 2022 | Jan 12, 2023 |
| DEFA14A | Additional proxy material | Jul 28, 2022 | — |
| DEFA14A | Additional proxy material | Jul 19, 2022 | — |
| DEFA14A | Additional proxy material | Jul 7, 2022 | — |
| DEF 14A | Proxy statement | Jun 17, 2022 | Aug 10, 2022 |
| PRE 14A | Preliminary proxy statement | Jun 7, 2022 | Aug 10, 2022 |
| DEFA14A | Additional proxy material | Jun 29, 2021 | — |
| DEFA14A | Additional proxy material | Jun 7, 2021 | — |
| DEF 14A | Proxy statement | Jun 7, 2021 | Jul 19, 2021 |
| PRE 14A | Preliminary proxy statement | May 26, 2021 | Jul 19, 2021 |
| DEFA14A | Additional proxy material | Jul 14, 2020 | — |
| DEFA14A | Additional proxy material | Jun 22, 2020 | — |
| DEF 14A | Proxy statement | Jun 22, 2020 | Aug 3, 2020 |
| PRE 14A | Preliminary proxy statement | Jun 10, 2020 | Aug 3, 2020 |
| DEFA14A | Additional proxy material | May 10, 2019 | — |
| DEF 14A | Proxy statement | May 10, 2019 | Jun 25, 2019 |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- YARW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1566044
- Former names
- VYNE Therapeutics Inc. (until Jul 24, 2026); Menlo Therapeutics Inc. (until Sep 2, 2020); Menlo Therapeutics, Inc. (until Jan 31, 2018); Tigercat Pharma, Inc. (until Jan 7, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.